Xencor (XNCR) Invested Capital (2022 - 2026)
Xencor (XNCR) posted quarterly Invested Capital of $26.4 million for Q1 2026, down 49.74% year-over-year from $52.5 million in Q1 2025, and down 38.96% quarter-over-quarter from $43.3 million in Q4 2025.
Analysis
Xencor (XNCR) Invested Capital (2022 - 2026) Analysis & Trends
Xencor (XNCR) has reported Invested Capital for 4 consecutive years, with $26.4 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Invested Capital fell 49.74% year-over-year to $26.4 million; the TTM figure through Mar 2026 stood at $165.3 million (down 10.33% YoY), while the FY2025 annual figure was $43.3 million, down 10.69% from the prior year.
- Invested Capital declined to $26.4 million in Q1 2026 per XNCR's latest filing, from $43.3 million in the prior quarter.
- Across five years, Invested Capital topped out at $52.5 million in Q1 2025 and bottomed at $26.4 million in Q1 2026.
- Historically, Invested Capital has averaged $41.2 million across 4 years, with a median of $43.9 million in 2024.
- Annual changes were most pronounced in 2024 — Invested Capital jumped 74.83% — and 2026, when it tumbled 49.74%.
- Xencor's Invested Capital stood at $27.7 million in 2023, then surged by 74.83% to $48.4 million in 2024, then decreased by 10.69% to $43.3 million in 2025, then sank by 38.96% to $26.4 million in 2026.
- Business Quant data shows XNCR's Invested Capital at $26.4 million in Q1 2026, $43.3 million in Q4 2025, and $45.4 million in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 33.70 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 7.35 Bn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 6.25 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 19.13 Bn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 1.30 Bn |
| 10 | Xencor | 2.02 Bn | 1.65 Bn | - | 608.12 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 608.12 Mn |
| Mar 31, 2026 | 624.17 Mn |
| Dec 31, 2025 | 755.34 Mn |
| Sep 30, 2025 | 758.45 Mn |
| Jun 30, 2025 | 765.37 Mn |
| Mar 31, 2025 | 794.25 Mn |
| Dec 31, 2024 | 837.63 Mn |
| Sep 30, 2024 | 878.72 Mn |
| Jun 30, 2024 | 728.47 Mn |
| Mar 31, 2024 | 784.83 Mn |
| Dec 31, 2023 | 851.57 Mn |
| Dec 31, 2022 | 727.50 Mn |